Retina Analysis
-
InvestorTalk Alert: Andre Larente from Diagnos Inc. to host on Tuesday, October 7, 2025
InvestorNews.com is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Tuesday, October 7, at 9 AM EST,…
-
André Larente on DIAGNOS’ Partnership with EssilorLuxottica to Expand AI Retinal Analysis and Offers Updates on Regulatory Approvals
September 09, 2024 — In a recent interview with InvestorNews host Pat Bolland, André Larente, President, CEO, and Director…
-
InvestorTalk Alert: Andre Larente from Diagnos Inc. to host on Thursday, September 5, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, September 5th, at 9 AM EST,…
-
Andre Larente from DIAGNOS to Host InvestorTalk (04.24.2024)
InvestorNews is hosting an InvestorTalk this morning with André Larente, CEO, President, and Director from DIAGNOS Inc. (TSXV:…
-
Andre Larente from DIAGNOS on Deal with World’s Largest Eyecare Retailer EssilorLuxottica
InvestorNews host Tracy Weslosky recently conducted an insightful interview with André Larente, President and Director of DIAGNOS Inc.…
-
Investor.Coffee (12.11.2023): CDN Healthcare Deal, U.S. Dollar Gains Strength on Japan’s Nikkei Rebound
DIAGNOS Inc. (TSXV: ADK | OTCQB: DGNOF), a company we have followed for several years out of Montreal, announced…
-
Eyes on DIAGNOS as commercialization gains momentum
The best time to buy an emerging company is when it begins commercialization. At this stage all the…
